DrugPatentWatch Database Preview
Ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate - Generic Drug Details
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What are the generic sources for ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate and what is the scope of patent protection?
Ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate
is the generic ingredient in three branded drugs marketed by Salix Pharms, Novel Labs Inc, and Salix, and is included in three NDAs. There are seven patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.Ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate has one hundred and fifty-five patent family members in thirty-nine countries.
There are six drug master file entries for ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate. Two suppliers are listed for this compound.
Summary for ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate
| International Patents: | 155 |
| US Patents: | 7 |
| Tradenames: | 3 |
| Applicants: | 3 |
| NDAs: | 3 |
| Drug Master File Entries: | 6 |
| Suppliers / Packagers: | 2 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate |
| DailyMed Link: | ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate at DailyMed |
Recent Litigation for ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate
Identify potential future generic entrants
District Court Litigation
| Case Name | Date |
|---|---|
| BAUSCH HEALTH IRELAND LIMITED v. LUPIN INC. | 2019-04-01 |
| Bausch Health Ireland Limited v. Lupin Ltd. |
Paragraph IV (Patent) Challenges for ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| PLENVU | FOR SOLUTION;ORAL | ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate | 209381 | 2018-12-06 |
| MOVIPREP | FOR SOLUTION;ORAL | ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate | 021881 | 2007-11-27 |
US Patents and Regulatory Information for ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate
International Patents for ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2006507281 | Start Trial |
| Turkey | 201909741 | Start Trial |
| South Africa | 201304866 | Start Trial |
| Austria | 404223 | Start Trial |
| Eurasian Patent Organization | 201700258 | Start Trial |
| Russian Federation | 2519562 | Start Trial |
| Russian Federation | 2353412 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
